The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Open accessAbstract
Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In families affected with multiple cases of schizophrenia, the deficit in P50 gating segregates as an autosomal dominant and is linked to the CHRNA7 gene complex, which forms the α7-nicotinic acetylcholine receptor (26).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [26]
Citations
Cites
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citationStrategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
- L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
- W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
- L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
- L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
- M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
- L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
- 10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI
Cited by
Sorted by citations
Items 201–300 of 1,000
Greenwood, T. A., Swerdlow, N. R., Gur, R. E., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. C., Lazzeroni, L. C., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020186 · Cited by 124
Self-citationNicotine Withdrawal and Psychiatric Symptoms in Cigarette Smokers with Schizophrenia
Dalack, G. W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00121-3 · Cited by 122
Yang, T., Xiao, T., Sun, Q. L., & Wang, K. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.09.001 · Cited by 127
Search for schizophrenia susceptibility genes
Pulver, A. E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00281-4 · Cited by 121
Hawkins, K. A., Mohamed, S., & Woods, S. W. (1999) · Psychological Medicine · doi:10.1017/s0033291798006990 · Cited by 120
"Schizotaxia": Clinical Implications and New Directions for Research
Faraone, S. V., Green, A. I., Seidman, L. J., & Tsuang, M. T. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006849 · Cited by 118
Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?
Catts, V. S., & Catts, S. V. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00077-8 · Cited by 119
Calkins, M. E., Iacono, W. G., & Öneş, D. S. (2008) · Brain and Cognition · doi:10.1016/j.bandc.2008.09.001 · Cited by 118
Imprinted genes, cognition and behaviour
Isles, A. R., & Wilkinson, L. S. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01504-7 · Cited by 118
Hall, M.-H., Schulze, K., Rijsdijk, F., Kalidindi, S., McDonald, C., Bramon, E., Murray, R. M., & Sham, P. (2009) · Psychological Medicine · doi:10.1017/s0033291709005261 · Cited by 117
Fallgatter, A. J., Herrmann, M. J., Roemmler, J., Ehlis, A., Wagener, A., Heidrich, A., Ortega, G., Zeng, Y., & Lesch, K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300409 · Cited by 117
Neuronal nicotinic acetylcholine receptors: from the gene to the disease
Weiland, S., Bertrand, D., & Leonard, S. S. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00199-6 · Cited by 117
Self-citationWinterer, G., Egan, M. F., Rädler, T., Hyde, T. M., Coppola, R., & Weinberger, D. R. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00128-6 · Cited by 116
Involvement of the cholinergic system in conditioning and perceptual memory
Robinson, L., Platt, B., & Riedel, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.055 · Cited by 115
Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia
Mohammadi, A., Rashidi, E., & Amooeian, V. G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.036 · Cited by 119
Riley, B. P., Williamson, M. P., Collier, D. A., Wilkie, H., & MAKOFF, A. J. (2002) · Genomics · doi:10.1006/geno.2002.6694 · Cited by 115
Role of α7 nicotinic receptors in nicotine dependence and implications for psychiatric illness
Nomikos, G. G., Schilström, B., Hildebrand, B. E., Panagis, G., Grenhoff, J., & Svensson, T. H. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00204-7 · Cited by 115
Elucidating the role of genetic factors in smoking behavior and nicotine dependence
Lerman, C., & Berrettini, W. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10003 · Cited by 114
Brunzell, D. H., & McIntosh, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.299 · Cited by 114
Avramopoulos, D., Stefanis, N. C., Hantoumi, I., Smyrnis, N., Evdokimidis, I., & STEFANIS, C. N. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001070 · Cited by 113
Weiser, M., Reichenberg, A., Rabinowitz, J., Kaplan, Z., Mark, M., Bodner, E., Nahon, D., & Davidson, M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.959 · Cited by 112
The role of cortical inhibition in the pathophysiology and treatment of schizophrenia
Daskalakis, Z. J., Fitzgerald, P. B., & Christensen, B. K. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.006 · Cited by 111
MK-801-induced expression of Fos protein family members in the rat retrosplenial granular cortex
Zhang, X., Fan, X.-D., Mohapel, P., Yu, P. H., & Boulton, A. A. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990901)57:5 · Cited by 7
Neuronal nicotinic receptors, important new players in brain function
Clementi, F., Fornasari, D., & Gotti, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00066-2 · Cited by 110
Toyohara, J., & Hashimoto, K. (2010) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501004010037 · Cited by 109
Nicotinic receptor desensitization and sensory gating deficits in schizophrenia
Griffith, J. M., O'Neill, J. E., Petty, F., Garver, D. L., Young, D. A., & Freedman, R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00362-4 · Cited by 109
Self-citationActivation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists
Briggs, C. A., & McKenna, D. G. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00110-5 · Cited by 108
Human and animal studies of schizophrenia-related gating deficits
Light, G. A., & BRAFF, D. L. (1999) · Current Psychiatry Reports · doi:10.1007/s11920-999-0008-y · Cited by 108
Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models
Chen, J., Lipska, B. K., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.024 · Cited by 108
Iacono, W. G. (1998) · Psychophysiology · doi:10.1111/1469-8986.3560621 · Cited by 110
Smith, R. C., Lindenmayer, J., Davis, J. M., Cornwell, J. A., Noth, K., Gupta, S., Sershen, H. W., & Lajtha, Á. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.02.001 · Cited by 107
Luca, V. D., Wong, A. H. C., Müller, D. J., Wong, G. W. H., Tyndale, R. F., & Kennedy, J. L. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300466 · Cited by 107
Normal Genetic Variation, Cognition, and Aging
Greenwood, P. M., & Parasuraman, R. (2003) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582303260641 · Cited by 110
Cuevas, J., & Berg, D. K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10335.1998 · Cited by 107
Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia
Tregellas, J. R., Tanabe, J., Rojas, D. C., Shatti, S., D, A. O. M., Johnson, L. L., Martín, L., Soti, F. S., Kem, W. R., Leonard, S. S., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.004 · Cited by 106
Self-citationNicotinic receptors and schizophrenia
Ripoll, N., Grall‐Bronnec, M., & Bourin, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004060 · Cited by 106
Human chromosome 15q11-q14 regions of rearrangements contain clusters of LCR15 duplicons
Pujana, M. Á., Nadal, M., Guitart, M., Armengol, L., Gratacòs, M., & Estivill, X. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200760 · Cited by 105
Turetsky, B. I., Cannon, T. D., & Gur, R. E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00290-5 · Cited by 106
Evidence for the multigenic inheritance of schizophrenia
Freedman, R., Leonard, S. S., D, A. O. M., Kaufmann, C. A., Malaspina, D., Cloninger, C. R., Švrakić, D. M., Faraone, S. V., & Tsuang, M. T. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10100 · Cited by 105
Self-citationSmoking Behaviour and Mental Health Disorders—Mutual Influences and Implications for Therapy
Minichino, A., Bersani, F. S., Calò, W. K., Spagnoli, F., Francesconi, M., Vicinanza, R., Chiaie, R. D., & Biondi, M. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10104790 · Cited by 110
Substantial Shared Genetic Influences on Schizophrenia and Event-Related Potentials
Hall, M., Rijsdijk, F. V., Picchioni, M., Schulze, K., Ettinger, U., Toulopoulou, T., Bramon, E., Murray, R. M., & Sham, P. C. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.804 · Cited by 103
Recent progress in psychiatric genetics--some hope but no hype
Stoltenberg, S. F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.927 · Cited by 103
Yasui, D. H., Scoles, H. A., Horike, S., Meguro‐Horike, M., Dunaway, K. W., Schroeder, D. I., & LaSalle, J. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr357 · Cited by 104
Hashimoto, K., Ishima, T., Fujita, Y., Matsuo, M., Kobashi, T., Takahagi, M., Tsukada, H., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.034 · Cited by 102
Alkondon, M., Braga, M. F. M., Pereira, E. F. R., Maelicke, A., & Albuquerque, E. X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00006-6 · Cited by 102
Application of Electroencephalography to the Study of Cognitive and Brain Functions in Schizophrenia
van der Stelt, O., & Belger, A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm016 · Cited by 105
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia
Martin-Ruiz, C. M., Haroutunian, V. H., Long, P., Young, A. H., Davis, K. L., Perry, E. K., & Court, J. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00348-2 · Cited by 100
Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers
Mexal, S., Berger, R., Logel, J., Ross, R. G., Freedman, R., & Leonard, S. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9233-4 · Cited by 101
Self-citationPotter, A., NEWHOUSE, P. A., & Bucci, D. J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.09.015 · Cited by 101
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800403 · Cited by 100
Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders
Léna, C., & Changeux, J. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80088-8 · Cited by 101
Wing, V. C., Wass, C., Soh, D. W., & George, T. P. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06261.x · Cited by 99
Schulze, K. K., Hall, M., McDonald, C., Marshall, N., Walshe, M., Murray, R. M., & Bramon, E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.006 · Cited by 99
Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital
de León, J., Tracy, J., McCann, E. M., McGrory, A., & Díaz, F. J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00192-x · Cited by 99
Han, Z., Zoli, M., Cardona, A., Bourgeois, J., Changeux, J., & Novère, N. G. L. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10659 · Cited by 102
A Turning Point in Schizophrenia Genetics
Karayiorgou, M., & Gogos, J. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80390-6 · Cited by 99
Relative Risk of Neurological Signs in Siblings of Patients With Schizophrenia
Egan, M. F., Hyde, T. M., Bonomo, J., Mattay, V. S., Bigelow, L. B., Goldberg, T. E., & Weinberger, D. R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1827 · Cited by 99
The Role of DNA Copy Number Variation in Schizophrenia
Tam, G. W. C., Redon, R., Carter, N. P., & Grant, S. G. N. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.027 · Cited by 98
Walling, D. P., Marder, S. R., Kane, J. M., Fleischhacker, W. W., Keefe, R. S. E., Hosford, D. A., Dvergsten, C., Segreti, A. C., Beaver, J. S., Toler, S. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv072 · Cited by 98
Low Olfactory Bulb Volume in First-Degree Relatives of Patients With Schizophrenia
Turetsky, B. I., Moberg, P. J., Arnold, S. E., Doty, R. L., & Gur, R. E. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.703 · Cited by 98
Souery, D., Lipp, O., Rivelli, S. K., Massat, I., Serretti, A., Cavallini, M. C., Ackenheil, M., Adolfsson, R., Aschauer, H. N., Blackwood, D., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991015)88:5 · Cited by 19
Self-citationAdvances in endophenotyping schizophrenia
BRAFF, D. L., Greenwood, T. A., Swerdlow, N. R., Light, G. A., & Schork, N. J. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00140.x · Cited by 97
Stephens, S. H., Logel, J., Barton, A., Franks, A. L., Finlay-Schultz, J., Short, M., Dickenson, J., James, B., Fingerlin, T. E., Wagner, B. D., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.12.017 · Cited by 97
Self-citationFernandes, C., Hoyle, E., Dempster, E. L., Schalkwyk, L. C., & Collier, D. A. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00176.x · Cited by 97
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
Hyde, T. M., & Crook, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00101-6 · Cited by 97
Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96
Carving Chaos: Genetics and the Classification of Mood and Psychotic Syndromes
Potash, J. B. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220600655780 · Cited by 96
Animal Models of Schizophrenia
Young, J. W., Zhou, X., & Geyer, M. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_62 · Cited by 97
Translational research in central nervous system drug discovery
Hurko, O., & Ryan, J. L. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.671 · Cited by 96
Horrobin, D. F., & Bennett, C. N. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.1999.0027 · Cited by 96
Genetic overlap between bipolar illness and event-related potentials
Hall, M., Rijsdijk, F. V., Kalidindi, S., SCHULZE, K., Kravariti, E., Kane, F., Sham, P. C., Bramon, E., & Murray, R. M. (2007) · Psychological Medicine · doi:10.1017/s003329170600972x · Cited by 95
Maziade, M., Mérette, C., Cayer, M., Roy, M., Szatmári, P., Côté, R., & Thivierge, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1077 · Cited by 97
Albuquerque, E. X., Pereira, E. F. R., Mike, Á., Eisenberg, H. M., Maelicke, A., & Alkondon, M. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00208-4 · Cited by 95
Benefits and pitfalls encountered in psychiatric genetic association studies
Malhotra, A. K., & Goldman, D. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00365-5 · Cited by 95
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
Shiina, A., Shirayama, Y., Niitsu, T., Hashimoto, T., Yoshida, T., Hasegawa, T., Haraguchi, T., Kanahara, N., Shiraishi, T., Fujisaki, M., et al. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-27 · Cited by 94
Cognitive functions in schizotypal personality disorder
Cadenhead, K. S., Perry, W., Shafer, K., & BRAFF, D. L. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00147-9 · Cited by 94
Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice
Young, J. W., Meves, J. M., Tarantino, I. S., Caldwell, S., & Geyer, M. A. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00711.x · Cited by 93
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 95
Allosteric nicotinic receptors, human pathologies
Léna, C., & Changeux, J. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80140-x · Cited by 93
Raux, G., Bonnet‐Brilhault, F., Louchart, S., Houy, E., Gantier, R., Levillain, D., Allio, G., Haouzir, S., Petit, M., Martinez, M. M., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001140 · Cited by 93
D, A. O. M., BRAFF, D. L., Adler, L. E., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Green, M. F., Greenwood, T. A., Gur, R. E., Gur, R. C., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.004 · Cited by 92
Self-citationGoldstein, J. M., Cherkerzian, S., Tsuang, M. T., & Petryshen, T. L. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32159 · Cited by 97
The myelin-pathogenesis puzzle in schizophrenia: a literature review
Karoutzou, G., Emrich, H. M., & Dietrich, D. E. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002096 · Cited by 95
The Structures of Neuronal Nicotinic Receptors
Lindstrom, J. M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_6 · Cited by 91
Castner, S. A., Smagin, G. N., Piser, T. M., Wang, Y., Smith, J. S., Christian, E. P., Mrzljak, L., & Williams, G. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.006 · Cited by 90
Espeseth, T., Greenwood, P. M., Reinvang, I., Fjell, A. M., Walhovd, K. B., Westlye, L. T., Wehling, E. I., Lundervold, A. J., Rootwelt, H., & Parasuraman, R. (2006) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/cabn.6.1.31 · Cited by 94
Inherited Auditory-Cortical Dysfunction in Twin Pairs Discordant for Schizophrenia
Ahveninen, J., Jääskeläinen, I. P., Osipova, D. V., HUTTUNEN, M. O., Ilmoniemi, R. J., Kaprio, J. A., Lönnqvist, J. K., Manninen, M., Pakarinen, S., Therman, S., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.015 · Cited by 90
Pershing, M. L., Bortz, D. M., Pocivavsek, A., Fredericks, P. J., Jørgensen, C. V., Vunck, S. A., Leuner, B., Schwarcz, R. M., & Bruno, J. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.017 · Cited by 92
Gamma/beta oscillation and sensory gating deficit in schizophrenia
Hong, L. E., Summerfelt, A. T., McMahon, R. P., Thaker, G. K., & Buchanan, R. W. (2003) · Neuroreport · doi:10.1097/00001756-200401190-00030 · Cited by 91
Greenberg, B. D., Li, Q., Lucas, F. R., Hu, S., Sirota, L. A., Benjamin, J., Lesch, K., Hamer, D. H., & Murphy, D. L. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000403)96:2 · Cited by 352
D, A. O. M., Ross, R. G., Harris, J. G., Young, D. A., McAndrews, M. A., Cawthra, E. M., McRae, K. A., Sullivan, B. F., Adler, L. E., & Freedman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00239-0 · Cited by 89
Self-citationMowry, B. J., & Nancarrow, D. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03399.x · Cited by 89
Genome-wide Linkage Analyses of Quantitative and Categorical Autism Subphenotypes
Liu, X.-Q., Paterson, A. D., & Szatmári, P. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.023 · Cited by 89
Mechanisms Underlying the Comorbidity of Tobacco Use in Mental Health and Addictive Disorders
Morisano, D., Bacher, I., Audrain-McGovern, J. E., & George, T. P. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400603 · Cited by 95
Sinkus, M. L., Lee, M. J., Gault, J., Logel, J., Short, M., Freedman, R., Christian, S. L., Lyon, J., & Leonard, S. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.041 · Cited by 89
Self-citationChamptiaux, N., & Changeux, J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339247 · Cited by 88
Phenotypic Markers as Risk Factors in Schizophrenia: Neurocognitive Functions
Michie, P. T., Kent, A. R., Stienstra, R., Castine, R., Johnston, J., Dedman, K., Wichmann, H., Box, J., Rock, D. J., Rutherford, E. M., et al. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/000486700226 · Cited by 88
Familial transmission of two independent saccadic abnormalities in schizophrenia
Ross, R. G., Harris, J. G., D, A. O. M., Radant, A. D., Adler, L. E., & Freedman, R. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00133-3 · Cited by 88
Self-citationMakoff, A. J., & Flomen, R. H. (2007) · Genome biology · doi:10.1186/gb-2007-8-6-r114 · Cited by 87
Will the Kraepelinian Dichotomy Survive DSM-V?
Fischer, B. A., & Carpenter, W. T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.32 · Cited by 87
Metadata
- Authors
- Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
- Affiliations
- Baylor College of Medicine (US)
- Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-01-21
- Volume
- 94
- Issue
- 2
- Pages
- 587-592
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19557
- OpenAlex
- W2144671685
- Cited by
- 1,141
- References
- 63
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
- National Institute on Aging (T32AG000029)
- National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
- National Institute on Drug Abuse (R01DA009457)
- National Center for Research Resources (P41RR003655, M01RR000064)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
- MeSH terms
- Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review